Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Aspirin

Known as: ácido acetilsalicílico, o-acetoxybenzoic acid, Acide 2-(acetyloxy)benzoique 
The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an… Expand
National Institutes of Health

Related topics

Related topics

46 relations
12 HR Aspirin 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule24 HR Aspirin 162.5 MG Extended Release Oral Capsule [Durlaza]ASA 325MG/CTM 2MG/P-EPHRINE 7.8MG TAB,EFFERVSCAcetaminophen 194 MG / Aspirin 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]
Expand

Narrower (18)

AggrenoxAscriptinColfaritEcotrin
Expand

Broader (5)

AnalgesicsAntipyreticsAntirheumatic AgentsCyclooxygenase Inhibitors
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers… Expand
Review
2019
Review
2019
EULAR recommendations for the management of antiphospholipid syndrome in adults
The objective was to develop evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults… Expand
Review
2019
Review
2019
Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion
  • R. Wong
  • Advances in pharmacological sciences
  • 2019
    • Corpus ID: 69164411
The nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed by medical practitioners in many clinical conditions… Expand
  • figure 1
Review
2019
Review
2019
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Pre-eclampsia is a complication of pregnancy that is associated with substantial maternal and fetal morbidity and mortality. The… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2019
Review
2019
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.
The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number of medical conditions; however, the… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Review
2019
Review
2019
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.
Importance The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary artery disease, in particular with… Expand
Review
2019
Review
2019
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk‐stratification and management
Disease Overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms respectively… Expand
Review
2019
Review
2019
The rise and fall of aspirin in the primary prevention of cardiovascular disease
Aspirin is one of the most frequently used drugs worldwide and is generally considered effective for the secondary prevention of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2018
Review
2018
Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment
Importance Acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure that affects… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 2
Review
2017
Review
2017
Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
BACKGROUND Aspirin-exacerbated respiratory disease (AERD) comprises the triad of chronic rhinosinusitis with nasal polyps (CRSwNP… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE